BMRN
Biomarin Pharmaceutical IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$10.30B
P/E Ratio
29.61
EPS
$1.80
Beta
0.29
52W High
$66.28
52W Low
$50.76
50-Day MA
$57.36
200-Day MA
$56.42
Dividend Yield
—
Profit Margin
10.80%
Forward P/E
10.64
PEG Ratio
0.63
About Biomarin Pharmaceutical Inc
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
Fundamentals
| Revenue (TTM) | $3.22B |
| Gross Profit (TTM) | $1.70B |
| EBITDA | $722.89M |
| Operating Margin | 22.50% |
| Return on Equity | 5.94% |
| Return on Assets | 5.58% |
| Revenue/Share (TTM) | $16.80 |
| Book Value | $31.65 |
| Price-to-Book | 1.71 |
| Price-to-Sales (TTM) | 3.20 |
| EV/Revenue | 2.932 |
| EV/EBITDA | 16.48 |
| Quarterly Earnings Growth (YoY) | 124.30% |
| Quarterly Revenue Growth (YoY) | 17.00% |
| Shares Outstanding | $193.27M |
| Float | $191.21M |
| % Insiders | 0.29% |
| % Institutions | 100.83% |
Historical Volatility
HV 10-Day
19.66%
HV 20-Day
24.05%
HV 30-Day
25.77%
HV 60-Day
26.07%
HV Rank
22.2%
Volatility is currently contracting
Analyst Ratings
Consensus ($90.17 target)
4
Strong Buy14
Buy5
HoldData last updated: 4/29/2026